Connect Biopharma Holdings Limited
CNTB
$2.65
-$0.01-0.38%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -- | -- | -- | -18.36M | -22.54M |
| Total Depreciation and Amortization | -- | -- | -- | 594.00K | 608.50K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | -- | 7.76M | 6.77M |
| Change in Net Operating Assets | -- | -- | -- | -19.11M | -14.42M |
| Cash from Operations | -- | -- | -- | -29.11M | -29.59M |
| Capital Expenditure | -- | -- | -- | -594.00K | -333.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | 1.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 5.04M | 33.09M |
| Cash from Investing | -- | -- | -- | 4.45M | 32.76M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 74.00K | 72.00K |
| Issuance of Common Stock | -- | -- | -- | 183.50K | 132.50K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | 257.50K | 204.50K |
| Foreign Exchange rate Adjustments | -- | -- | -- | 135.50K | 210.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | -- | -24.27M | 3.59M |